INmune Bio, Inc.
INmune Bio, Inc. is a Public Limited Company registered in United States, and its current status with Florida Department of State — Sunbiz is active. Its registered address on file is Boca Raton, United States. 5 shareholders are on record for INmune Bio, Inc., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Florida Department of State — Sunbiz and was last updated on 18 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Shareholders of INmune Bio, Inc.
Five shareholders are currently on record for INmune Bio, Inc., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is iShares Trust-iShares Russell 2000 ETF, holding 7.7% — the largest recorded stake — followed by Fidelity Salem Street Trust-Fidelity Small Cap Index Fund at 4.2%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Data availability
The register reports 9 shareholders in total, though only the top 5 by holding are shown in this view.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| iShares Trust-iShares Russell 2000 ETF | 7.7% | Florida Department of State — Sunbiz | |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 4.2% | Florida Department of State — Sunbiz | |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 1.8% | Florida Department of State — Sunbiz | |
| iShares Trust-iShares Micro-Cap ETF | 0.8% | Florida Department of State — Sunbiz | |
| -SSgA SPDR ETFS Europe I-SPDR Russell 2000 US Small Cap UCITS ETF | 0.6% | Florida Department of State — Sunbiz |
Officers
7
Directors and officers of INmune Bio, Inc.
The Co-founder, President, Ceo, Chief Medical Officer & Chairman of INmune Bio, Inc. currently on record is Raymond Joseph Tesi M.d.; seven officers are currently on record for INmune Bio, Inc., filed with Florida Department of State — Sunbiz. Management authority at INmune Bio, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Group structure of INmune Bio, Inc.
INmune Bio, Inc. has no recorded parent company — it sits at the top of its own group structure, with 3 subsidiaries recorded beneath it across 3 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- Cells, Inc. (United States)
- INMUNE BIO AUSTRALIA PTY LTD (Australia)
- INMUNE BIO INTERNATIONAL LIMITED (United Kingdom)
Data availability
Those 3 subsidiaries span United States, Australia, United Kingdom jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
INmune Bio, Inc.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns INmune Bio, Inc.?
Five shareholders are currently on record for INmune Bio, Inc., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is iShares Trust-iShares Russell 2000 ETF, holding 7.7% — the largest recorded stake — followed by Fidelity Salem Street Trust-Fidelity Small Cap Index Fund at 4.2%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is INmune Bio, Inc.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for INmune Bio, Inc. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does INmune Bio, Inc. have on record?
5 shareholders are shown on record for INmune Bio, Inc.. The register reports 9 in total; only the top 5 by holding are shown here.
Is INmune Bio, Inc. still an active company?
INmune Bio, Inc.'s status on Florida Department of State — Sunbiz is listed as active.
What is INmune Bio, Inc.'s registered address?
The registered address on file for INmune Bio, Inc. is Boca Raton, United States.
What legal structure is INmune Bio, Inc. registered as?
INmune Bio, Inc. is registered as a Public Limited Company in United States.
Who are the officers/directors of INmune Bio, Inc.?
The Co-founder, President, Ceo, Chief Medical Officer & Chairman of INmune Bio, Inc. currently on record is Raymond Joseph Tesi M.d.; seven officers are currently on record for INmune Bio, Inc., filed with Florida Department of State — Sunbiz. Management authority at INmune Bio, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does INmune Bio, Inc. have a parent company or subsidiaries?
INmune Bio, Inc. has no recorded parent company — it sits at the top of its own group structure, with 3 subsidiaries recorded beneath it across 3 jurisdictions. Those 3 subsidiaries span United States, Australia, United Kingdom jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to INmune Bio, Inc.'s ownership over time?
This profile reflects a point-in-time snapshot from Florida Department of State — Sunbiz. Zavia's monitoring API can track changes to INmune Bio, Inc.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access INmune Bio, Inc.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like INmune Bio, Inc.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Florida Department of State — Sunbiz and was last synced on 18 September 2026.